|
1
|
Stupp R, Mason WP, van den Bent MJ, et al:
Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma. N Engl J Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chin L and Gray JW: Translating insights
from the cancer genome into clinical practice. Nature. 452:553–563.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wiedemeyer R, Brennan C, Heffernan TP, et
al: Feedback circuit among INK4 tumor suppressors constrains human
glioblastoma development. Cancer Cell. 13:355–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dunn GP, Rinne ML, Wykosky J, et al:
Emerging insights into the molecular and cellular basis of
glioblastoma. Genes Dev. 26:756–784. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bonavia R, Inda MM, Cavenee WK and Furnari
FB: Heterogeneity maintenance in glioblastoma: a social network.
Cancer Res. 71:4055–4060. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sassen S, Miska EA and Caldas C: MicroRNA:
implications for cancer. Virchows Arch. 452:1–10. 2008. View Article : Google Scholar
|
|
8
|
Shenouda SK and Alahari SK: MicroRNA
function in cancer: oncogene or a tumor suppressor? Cancer
Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee ST, Chu K, Oh HJ, et al: Let-7
microRNA inhibits the proliferation of human glioblastoma cells. J
Neurooncol. 102:19–24. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kefas B, Godlewski J, Comeau L, et al:
microRNA-7 inhibits the epidermal growth factor receptor and the
Akt pathway and is down-regulated in glioblastoma. Cancer Res.
68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Papagiannakopoulos T, Shapiro A and Kosik
KS: MicroRNA-21 targets a network of key tumor-suppressive pathways
in glioblastoma cells. Cancer Res. 68:8164–8172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gabriely G, Wurdinger T, Kesari S, et al:
MicroRNA 21 promotes glioma invasion by targeting matrix
metalloproteinase regulators. Mol Cell Biol. 28:5369–5380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu J, Getz G, Miska EA, et al: MicroRNA
expression profiles classify human cancers. Nature. 435:834–838.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saini S, Yamamura S, Majid S, et al:
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in
renal cancer cells. Cancer Res. 71:6208–6219. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jang JS, Jeon HS, Sun Z, et al: Increased
miR-708 expression in NSCLC and its association with poor survival
in lung adenocarcinoma from never smokers. Clin Cancer Res.
18:3658–3667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Su CH, Zhao R, Zhang F, et al: 14–3–3sigma
exerts tumor-suppressor activity mediated by regulation of COP1
stability. Cancer Res. 71:884–894. 2011.
|
|
19
|
Vivanco I and Sawyers CL: The
phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev
Cancer. 2:489–501. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sommer G, Dittmann J, Kuehnert J, et al:
The RNA-binding protein La contributes to cell proliferation and
CCND1 expression. Oncogene. 30:434–444. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Suvà ML, Riggi N, Janiszewska M, et al:
EZH2 is essential for glioblastoma cancer stem cell maintenance.
Cancer Res. 69:9211–9218. 2009.PubMed/NCBI
|
|
22
|
Orzan F, Pellegatta S, Poliani PL, et al:
Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and
in glioma stem-like cells. Neuropathol Appl Neurobiol. 37:381–394.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo Y, Liang F and Zhang ZY: PRL1 promotes
cell migration and invasion by increasing MMP2 and MMP9 expression
through Src and ERK1/2 pathways. Biochemistry. 48:1838–1846. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sugo N, Niimi N, Aratani Y, Masutani M,
Suzuki H and Koyama H: Decreased PARP-1 levels accelerate embryonic
lethality but attenuate neuronal apoptosis in DNA polymerase
β-deficient mice. Biochem Biophys Res Commun. 354:656–661.
2007.PubMed/NCBI
|
|
25
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang C, Zhang J, Hao J, et al: High level
of miR-221/222 confers increased cell invasion and poor prognosis
in glioma. J Transl Med. 10:1192012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang J, Han L, Ge Y, et al: miR-221/222
promote malignant progression of glioma through activation of the
Akt pathway. Int J Oncol. 36:913–920. 2010.PubMed/NCBI
|
|
28
|
Guessous F, Alvarado-Velez M,
Marcinkiewicz L, et al: Oncogenic effects of miR-10b in
glioblastoma stem cells. J Neurooncol. 112:153–163. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jain M, Kumar S, Upadhyay R, et al:
Influence of apoptosis (BCL2, FAS), cell cycle (CCND1) and growth
factor (EGF, EGFR) genetic polymorphisms on survival outcome: an
exploratory study in squamous cell esophageal cancer. Cancer Biol
Ther. 6:1553–1558. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lebeau A, Unholzer A, Amann G, et al:
EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell
proliferation and steroid hormone receptor status in ductal
carcinoma in situ of the breast. Breast Cancer Res Treat.
79:187–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livant DL: Targeting invasion induction as
a therapeutic strategy for the treatment of cancer. Curr Cancer
Drug Targets. 5:489–503. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Westermarck J and Kähäri VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999.PubMed/NCBI
|
|
33
|
Ren G, Baritaki S, Marathe H, et al:
Polycomb protein EZH2 regulates tumor invasion via the
transcriptional repression of the metastasis suppressor RKIP in
breast and prostate cancer. Cancer Res. 72:3091–3104. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rao ZY, Cai MY, Yang GF, et al: EZH2
supports ovarian carcinoma cell invasion and/or metastasis via
regulation of TGF-β1 and is a predictor of outcome in ovarian
carcinoma patients. Carcinogenesis. 31:1576–1583. 2010.
|
|
35
|
Subramanian S and Steer CJ: MicroRNAs as
gatekeepers of apoptosis. J Cell Physiol. 223:289–298.
2010.PubMed/NCBI
|
